Institutional Research Archive

Hedge Fund Letters Archive

Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Themes	Quick Take

Home Letters Funds Account

Meridian Small Cap Growth Fund 2024 Q3 Investor Letter | Buyside Digest

Back to Fund Profile (Meridian Small Cap Growth Fund)

Primary Source Intelligence • Q3 2024 Letter Analysis

Meridian Small Cap Growth Fund Quarterly Analysis

Buyside Digest is not affiliated with, and does not endorse, Meridian Small Cap Growth Fund. This analysis is provided for institutional research purposes only and is not investment advice.

Fund Returns

QTD+6.15%

Annualized+8.61%

Digest Analysis

Quick Take

"Underperforming its benchmark due to headwinds from high-momentum market leadership versus their valuation-disciplined approach. The defensive strategy effectively protected downside during volatile periods."

Executive Summary

The Meridian Small Cap Growth Fund returned 6.15% net in Q3 2024, underperforming the Russell 2000 Growth Index's 8.41% return. The fund's investment approach emphasizes high-quality businesses with recurring revenue, sustainable competitive advantages, and downside protection over return maximization. This defensive positioning proved effective during market volatility, outperforming the index on five of six days when it declined 2% or more. The strategy favors companies with steady revenue streams and attractive valuations, currently found lower on the capitalization spectrum. Positive stock selection in consumer staples, energy, and healthcare aided returns, while select holdings in industrials, financials, and consumer discretionary detracted. Top contributors included Byrna Technologies, Everi Holdings, and Turning Point Brands, while detractors were Stoneridge, LegalZoom, and Vivid Seats. Looking forward, the fund remains cautious on consumer-facing stocks given ongoing price pressures but is gaining confidence in healthcare given attractive valuations and improving fundamentals. The strategy maintains focus on quality businesses with stable revenues priced attractively.

Unlock Full Institutional Analysis

Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.

Sign In to Unlock (3 Free Credits)View Pricing Tiers

Institutional Meta Strategy

Meta Strategy Gauges

Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.

Signal Matrix

Market Conviction

65%

CautiousHigh

Moderate (65%)

The fund demonstrates moderate conviction with named top 10 holdings representing specific percentages and detailed commentary on individual positions. Clear investment thesis around quality businesses with downside protection, though diversified approach with multiple small positions limits overall conviction score.

Growth Outlook

25%

BearishBullish

Bearish (25%)

The manager expresses cautious optimism about Fed rate cuts and potential soft landing, but acknowledges significant headwinds including 12-18 month lag for rate cut benefits and ongoing consumer price pressures. Healthcare outlook is improving but consumer environment remains challenging.

Risk Appetite

0%

DefensiveAggressive

Defensive (0%)

Portfolio positioning appears balanced with sector rotations rather than directional changes. The fund maintains underweight consumer exposure while overweighting healthcare, suggesting selective rather than aggressive risk-taking.

Capital Deployment

5%

De-riskingDeploying

De-risking (5%)

Limited deployment activity with trimming of appreciated positions (Byrna, Turning Point Brands) and maintaining positions in challenged names. No indication of significant cash level changes or aggressive new position building.

Forward Guidance

10%

CautiousExpansionary

Cautious (10%)

Manager indicates selective deployment with cautious approach to consumer stocks and gradual confidence building in healthcare. No indication of aggressive capital deployment or major positioning changes planned.

Language Signal

15%

BearishBullish

Bearish (15%)

Language is balanced with both opportunity and risk mentions. Positive language around healthcare prospects and Fed cuts is offset by caution on consumer environment and ongoing economic pressures.

Perceived Risk

55%

Low RiskElevated

Moderate Risk (55%)

Manager identifies several specific risks including 12-18 month lag for rate cut benefits, ongoing consumer price pressures, challenging small business environment, and competitive pressures in entertainment. Risks are named and discussed but not characterized as systemic threats.

Opportunity Density

45%

ScarceAbundant

Selective (45%)

Manager sees selective opportunities, particularly in healthcare where valuations are attractive, but emphasizes the need for selectivity and patience. Consumer environment limits opportunity set, suggesting moderate but not abundant opportunities.

Time Horizon

70%

Short-TermLong-Term

Decade+ (70%)

The fund emphasizes long-term growth of capital as its objective and demonstrates patience with challenged positions like LegalZoom and Stoneridge. Strategy focuses on sustainable competitive advantages and resilient portfolio construction, indicating multi-year investment horizon.